Cargando…

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives

Prion diseases are transmissible progressive neurodegenerative conditions characterized by rapid neuronal loss accompanied by a heterogeneous neuropathology, including spongiform degeneration, gliosis and protein aggregation. The pathogenic mechanisms and the origins of prion diseases remain unclear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanata, Eirini, Thüne, Katrin, Xanthopoulos, Konstantinos, Ferrer, Isidre, Dafou, Dimitra, Zerr, Inga, Sklaviadis, Theodoros, Llorens, Franc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064744/ https://www.ncbi.nlm.nih.gov/pubmed/30083102 http://dx.doi.org/10.3389/fnagi.2018.00220

Ejemplares similares

RNA editing alterations define manifestation of prion diseases
por: Kanata, Eirini, et al.
Publicado: (2019)

Carnosic Acid and Carnosol Display Antioxidant and Anti-Prion Properties in In Vitro and Cell-Free Models of Prion Diseases
por: Karagianni, Korina, et al.
Publicado: (2022)

Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning
por: Founta, Kyriaki, et al.
Publicado: (2023)

A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations
por: Karagianni, Korina, et al.
Publicado: (2022)

Profiling Microglia through Single-Cell RNA Sequencing over the Course of Development, Aging, and Disease
por: Pettas, Spyros, et al.
Publicado: (2022)

Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis
por: Llorens, Franc, et al.
Publicado: (2018)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

Photo-Fenton and TiO(2) Photocatalytic Inactivation of Model Microorganisms under UV-A; Comparative Efficacy and Optimization
por: Kanata, Eirini, et al.
Publicado: (2023)

Cerebrospinal fluid neurogranin as a new player in prion disease diagnosis and prognosis
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Subtype and Regional-Specific Neuroinflammation in Sporadic Creutzfeldt–Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2014)

Synthesis, structural characterization and study of antioxidant and anti-PrP(Sc) properties of flavonoids and their rhenium(I)–tricarbonyl complexes
por: Glykofridi, Pigi, et al.
Publicado: (2023)

The role of cellular prion protein in lipid metabolism in the liver
por: Arora, Amandeep Singh, et al.
Publicado: (2020)

Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients
por: Schmitz, Matthias, et al.
Publicado: (2016)

TREM2 expression in the brain and biological fluids in prion diseases
por: Diaz-Lucena, Daniela, et al.
Publicado: (2021)

RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE)
por: Dafou, Dimitra, et al.
Publicado: (2022)

Assessing Proteinase K Resistance of Fish Prion Proteins in a Scrapie-Infected Mouse Neuroblastoma Cell Line
por: Salta, Evgenia, et al.
Publicado: (2014)

Immunization with Recombinant Prion Protein Leads to Partial Protection in a Murine Model of TSEs through a Novel Mechanism
por: Xanthopoulos, Konstantinos, et al.
Publicado: (2013)

Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis
por: Zerr, Inga, et al.
Publicado: (2020)

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
por: Candelise, Niccolo, et al.
Publicado: (2020)

Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
por: Zerr, Inga, et al.
Publicado: (2019)

Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease
por: Llorens, Franc, et al.
Publicado: (2020)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease
por: Zerr, Inga, et al.
Publicado: (2021)

Prion2022-pushing the boundaries
por: Zerr, Inga
Publicado: (2023)

Progress in CSF biomarker discovery in sCJD
por: Llorens, Franc, et al.
Publicado: (2016)

YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés-Benito, Pol, et al.
Publicado: (2018)

Application of an in vitro-amplification assay as a novel pre-screening test for compounds inhibiting the aggregation of prion protein scrapie
por: Schmitz, Matthias, et al.
Publicado: (2016)

Human prion diseases: progress in clinical trials
por: Zerr, Inga
Publicado: (2013)

Prion 2022 Conference abstracts: pushing the boundaries
por: Zerr, Inga
Publicado: (2022)

An Update on Autophagy in Prion Diseases
por: López-Pérez, Óscar, et al.
Publicado: (2020)

Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés‐Benito, Pol, et al.
Publicado: (2021)

Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease
por: Shafiq, Mohsin, et al.
Publicado: (2021)

Perspectives of a scrapie resistance breeding scheme targeting Q211, S146 and K222 caprine PRNP alleles in Greek goats
por: Kanata, Eirini, et al.
Publicado: (2014)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
por: Llorens, Franc, et al.
Publicado: (2017)

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
por: Schmitz, Matthias, et al.
Publicado: (2022)

BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers
por: López-Pérez, Óscar, et al.
Publicado: (2020)

Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer’s Disease
por: Podlesniy, Petar, et al.
Publicado: (2020)

Application of antibody phage display to identify potential antigenic neural precursor cell proteins
por: Paspaltsis, Ioannis, et al.
Publicado: (2020)

Species and Strain Glycosylation Patterns of PrP(Sc)
por: Xanthopoulos, Konstantinos, et al.
Publicado: (2009)

Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
por: López González, Irene, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mplnkq4g4ifvjep29vras5cqfk